Last updated on November 21st, 2022The doctor prescribes Janumet for the elderly suffering from skeletal muscle dysfunction to control their blood sugar levels. Janumet 50 mg/500 mg Tablet is a combination of two medications: Sitagliptin 50 mg and Metformin 500 mg. The chances of side effects like weight gain and low blood sugar levels are lesser …
Last updated on September 28th, 2022Metformin is a very popular and commonly used oral medication for treating and managing type-2 diabetes. The objective of the treatment of type-2 diabetes is to mainly manage blood glucose levels. The blood glucose levels of the body fluctuate due to the body’s resistance to insulin and the reduction in insulin …
Last updated on September 9th, 2022 Summary Diabetes is a severe condition and can lead to severe health issues in the body over some time. Considering it can affect the overall working of the organs of the body. People who have type 2 diabetes need to be even more careful. Inadequately managed blood sugar can result …
Last updated on March 7th, 2022Glycomet GP2 Tablet is a medicine used to treat type 2 diabetes mellitus. It is a proven fact that diabetes can affect your overall well-being. When blood sugar is not managed properly it can result in a variety of health issues. The medicine comes to use here as it helps in …
Last updated on September 27th, 2022Tenglyn M 500 Tablet belongs to the class of drugs known as ‘antidiabetic agents,’ used to treat Type 2 diabetes. In diabetic patients who do not respond well to Metformin alone, this drug improves glycemic control. Diabetes mellitus type 2 is a long-term or chronic disorder in which blood sugar levels …
Last updated on March 2nd, 2022Glycomet GP 1 Tablet is a mixture of Glimepiride and Metformin, two anti-diabetic medicines. The sulfonylurea glimepiride works by raising the amount of insulin produced by the pancreas. Metformin, a ‘biguanide,’ works by decreasing glucose synthesis in the liver, slowing glucose absorption in the intestines, and enhancing the body’s insulin response. …